University Of Maryland Announces New Partnerships With AstraZeneca, NIH And FDA

Study in US: While celebrating its second anniversary, the University of Maryland Institute for Health Computing announced new partnerships with AstraZeneca, NIH, and the FDA.

To support public health, the University of Maryland Institute for Health Computing uses artificial intelligence and high-performance computing.

A few of the medical advances made while using these technologies are predicting the spread of disease and identifying patients with antibiotic-resistant infections. To celebrate the second anniversary, the institute welcomed many leaders from state government, Montgomery County, federal agencies and life science companies to its headquarters in North Bethesda. The event saw a ribbon-cutting ceremony and research showcasing by the institute.

“We are truly poised to take advantage of these breakthroughs because of our location, our partnerships with biotech companies right here in Montgomery County, and of course, wonderful agencies such as NIH, FDA and NIST,” said the University of Maryland, College Park President Darryll J. Pines.

University Of Maryland Institute For Health Computing Accomplishments

The institute's accomplishments to date include over 150 scientific papers published, 10 industry partnerships formed, 26 grant applications submitted in just the last quarter, two scientific patents submitted, and one spin-off company launched.

Montgomery County Executive Marc Elrich commented, "All of this innovation energy is the result of blending the advanced computing expertise of UMCP, clinical and biomedical research experts from the University of Maryland, Baltimore (UMB) and a vast database of health information provided by the University of Maryland Medical System (UMMS). The shared goal is to improve well-being and quality of life, fight disease and enhance outcomes for all people across Maryland and beyond. The center also provides new educational and employment opportunities to the community."

University of Maryland Strategic Partnership: MPowering the State and Montgomery County is funding this institute.

Aldo Badano, director of the FDA’s Division of Imaging, Diagnostics and Software Reliability commented, “I'm very excited to announce … that we are in final stages of an agreement that will allow for FDA scientists to actually be here in this floor, working alongside university researchers and clinicians. This convergence between the FDA regulatory science expertise and the IHC’s innovation—in the university systems, in the health systems and also industries that are associated in the partnership—really promises to bring benefits to patients, which is always our first customer at FDA, but also in workforce development, which FDA really appreciates."

Read more:

• University Of Strathclyde Offers British Council GREAT Scholarships 2025 For Justice And Law Worth £10,000
• University Of Guelph Introduces Course On Taylor Swift